« Previous
Next »
Titles
- FDA could take stronger enforcement action against tobacco retailers with histories of sales to youth and other violations1
- FDA repeatedly adapted emergency use authorization policies to address the need for COVID-19 testing1
- FDA’s approach to overseeing online tobacco retailers needs improvement1
- FDA’s work with the tri-agency task force for emergency diagnostics helped labs implement COVID-19 tests1
- Fact sheet. The 340B Drug Pricing Program1
- Federal budgetary effects of the activities of the Center for Medicare & Medicaid Innovation1
- Federal subsidies for health insurance: 2023 to 20331
- Federal survey sample size analysis: disability, language, and sexual orientation and gender identity1
- For Medicaid-enrolled children diagnosed with lead toxicity in five states, documentation reviewed for diagnoses and treatment services raises concerns1
- Forward-looking labor supply responses to changes in pension wealth: evidence from Germany1
- Fostering medical device improvement: FDA activities and engagement with the voluntary improvement program : guidance for industry and Food and Drug Administration staff1
- Four in ten adults with disabilities experienced unfair treatment in health care settings, at work, or when applying for public benefits in 20221
- Four states reviewed received increased Medicaid COVID-19 funding even though they terminated some enrollees’ coverage for unallowable or potentially unallowable reasons1